The elmiric acids: biologically active anandamide analogs.
elmiric Acids:具有生物活性的 anandamide 类似物。
基本信息
- 批准号:7894890
- 负责人:
- 金额:$ 32.43万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-08-01 至 2012-01-31
- 项目状态:已结题
- 来源:
- 关键词:2-arachidonylglycerolAbbreviationsAbsence of pain sensationAcidsAcuteAdverse effectsAirAmidohydrolasesAnabolismAnti-Inflammatory AgentsAnti-inflammatoryApplications GrantsBindingBiologicalBiological AssayBiological ModelsBrainCNR1 geneCalcium ionCannabinoidsCategoriesCell Culture TechniquesCell physiologyCellsChemical StructureChemicalsChinese Hamster Ovary CellChronicCommunitiesDataDependencyDrug usageEndocannabinoidsEnzyme-Linked Immunosorbent AssayEnzymesExposure toFamilyFamily memberFibroblastsFutureGene SilencingGlycineGoalsHydrolysisImmunoassayIn VitroInflammationInflammatoryInflammatory ResponseInhibition of Cell ProliferationInjuryInterleukin-6InterleukinsLigandsLinkLipopolysaccharidesLipoxygenaseLiquid substanceMass Spectrum AnalysisMeasuresMediatingMediator of activation proteinMedicalModelingMolecularMusN-arachidonylglycineNamesNarcoticsNomenclatureNon-Steroidal Anti-Inflammatory AgentsNuclearOrphanPainPeritoneal FluidPeritonitisPharmaceutical PreparationsPhysiologicalPlatelet Activating FactorProceduresProstaglandin-Endoperoxide SynthaseProstaglandinsRattusReportingResearch SupportRheumatoid ArthritisRiskRoleSamplingScintillation CountingStructure-Activity RelationshipSuggestionSynovial CellSystemTNF geneTRPV1 geneTestingTetrahydrocannabinolThioglycolatesTimeTissuesTumor Necrosis Factor-alphaTumor Necrosis FactorsWorkaddictionajulemic acidamidaseanaloganandamidebasecapsaicin receptorcytokinefallsfatty acid amide hydrolasefollow-upgamma-Aminobutyric Acidgamma-Linolenic Acidglycine transporterhuman GPRC5C proteinin vitro Modelin vivoinhibitor/antagonistinnovationinsightinterestmembermonocytenovelperipheral bloodprogesterone 11-hemisuccinate-(2-iodohistamine)receptorresearch studyresponsesubcutaneous
项目摘要
As chemical entities, lipoamino acids have been known for some time. However, more
recently their occurrence and importance in mammalian species has been discovered. They
appear to have close relationships with the endocannabinoids not only structurally but also
in terms of biological actions. The latter include analgesia, anti-inflammatory effects,
inhibition of cell proliferation and calcium ion mobilization. To date about 40 naturally
occurring members of this family have been identified and, additionally, several synthetic
analogs have been prepared and studied. To facilitate their identity, a nomenclature system
has been suggested based on the name elmiric acid (EMA). The prototypic example, N-arachidonoyl glycine does not bind to CBI, however it does inhibit the glycine transporter
GLYT2a and also appears to be a ligand for the orphan G-protein-coupled receptor GPRI8.
It may also have a role in regulating tissue levels of anandamide by virtue of its inhibitory
effect on FAAH the enzyme that mediates inactivation of anandamide. Its concentration in
rat brain is several times higher than anandamide supporting its possible role as a
physiological mediator. Future studies should be aimed at elucidating the actions of all of
the members of this interesting family of molecules and gaining further insight into possible
mechanisms of action. A promising use for these compounds would be as narcotic
replacement agents.
作为化学实体,脂氨基酸已知已有一段时间了。然而,更多
最近,人们发现了它们在哺乳动物物种中的出现和重要性。他们
似乎不仅在结构上而且在结构上与内源性大麻素有密切的关系
从生物作用来看。后者包括镇痛、抗炎作用、
抑制细胞增殖和钙离子动员。迄今为止自然约40
该家族的出现成员已被鉴定,此外,还有一些合成的
类似物已被制备和研究。为了便于识别,命名系统
已根据名称 elmiric Acid (EMA) 提出建议。原型示例 N-花生四烯酰甘氨酸不与 CBI 结合,但它会抑制甘氨酸转运蛋白
GLYT2a 似乎也是孤儿 G 蛋白偶联受体 GPRI8 的配体。
由于其抑制作用,它还可能在调节 anandamide 的组织水平方面发挥作用。
对介导 anandamide 失活的 FAAH 酶的影响。其浓度在
大鼠大脑比 anandamide 高几倍,支持其可能作为
生理介质。未来的研究应该旨在阐明所有的行动
这个有趣的分子家族的成员,并进一步了解可能的
行动机制。这些化合物的一个有前景的用途是用作麻醉剂
替代代理。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SUMNER HOWARD BURSTEIN其他文献
SUMNER HOWARD BURSTEIN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SUMNER HOWARD BURSTEIN', 18)}}的其他基金
The elmiric acids: biologically active anandamide analogs.
elmiric Acids:具有生物活性的 anandamide 类似物。
- 批准号:
7727687 - 财政年份:2009
- 资助金额:
$ 32.43万 - 项目类别:
Endocannabinoid Analogs as Anti-inflammatory Agents
作为抗炎剂的内源性大麻素类似物
- 批准号:
7106374 - 财政年份:2004
- 资助金额:
$ 32.43万 - 项目类别:
Endocannabinoid Analogs as Anti-inflammatory Agents
作为抗炎剂的内源性大麻素类似物
- 批准号:
6951593 - 财政年份:2004
- 资助金额:
$ 32.43万 - 项目类别:
Endocannabinoid Analogs as Anti-inflammatory Agents
作为抗炎剂的内源性大麻素类似物
- 批准号:
6749403 - 财政年份:2004
- 资助金额:
$ 32.43万 - 项目类别:
Endocannabinoid Analogs as Anti-inflammatory Agents
作为抗炎剂的内源性大麻素类似物
- 批准号:
7678732 - 财政年份:2004
- 资助金额:
$ 32.43万 - 项目类别:
NON PSYCHOACTIVE CANNABINOIDS WITH THERAPEUTIC POTENTIAL
具有治疗潜力的非精神活性大麻素
- 批准号:
6175550 - 财政年份:1999
- 资助金额:
$ 32.43万 - 项目类别:
NON PSYCHOACTIVE CANNABINOIDS WITH THERAPEUTIC POTENTIAL
具有治疗潜力的非精神活性大麻素
- 批准号:
2902241 - 财政年份:1999
- 资助金额:
$ 32.43万 - 项目类别:
NON PSYCHOACTIVE CANNABINOIDS WITH THERAPEUTIC POTENTIAL
具有治疗潜力的非精神活性大麻素
- 批准号:
6378830 - 财政年份:1999
- 资助金额:
$ 32.43万 - 项目类别:
NON PSYCHOACTIVE CANNABINOIDS WITH THERAPEUTIC POTENTIAL
具有治疗潜力的非精神活性大麻素
- 批准号:
6515659 - 财政年份:1999
- 资助金额:
$ 32.43万 - 项目类别:
BIOSYNTHESIS OF ANANDAMIDE--A NOVEL EICOSANOID
新型二十烷酸阿南达胺的生物合成
- 批准号:
2122673 - 财政年份:1995
- 资助金额:
$ 32.43万 - 项目类别:
相似海外基金
Real-time Disambiguation of Abbreviations in Clinical Notes
临床记录中缩写词的实时消歧
- 批准号:
8077875 - 财政年份:2010
- 资助金额:
$ 32.43万 - 项目类别:
Real-time Disambiguation of Abbreviations in Clinical Notes
临床记录中缩写词的实时消歧
- 批准号:
7866149 - 财政年份:2010
- 资助金额:
$ 32.43万 - 项目类别:
Real-time Disambiguation of Abbreviations in Clinical Notes
临床记录中缩写词的实时消歧
- 批准号:
8589822 - 财政年份:2010
- 资助金额:
$ 32.43万 - 项目类别:
Real-time Disambiguation of Abbreviations in Clinical Notes
临床记录中缩写词的实时消歧
- 批准号:
8305149 - 财政年份:2010
- 资助金额:
$ 32.43万 - 项目类别:














{{item.name}}会员




